Shout out to our very own Meagan R. Pitcher, Ph.D. for being selected as a panelist for MedTech Malta! Great work by Giovanni Lauricella for putting together such a fantastic group.
At #MedTechMalta2024, we’re excited to explore Houston’s role as a MedTech powerhouse. Leading experts from the Houston MedTech ecosystem will discuss why #Houston is becoming a global hub for medical innovation on Day 1 at the La Vallette Stage. 🗣 Giovanni Lauricella, CEO of Lifeblood, will kick off our exploration of Houston’s MedTech landscape. He’ll be joined by Homer Quintana, Director at the Center for Rapid Device Translation at Houston Methodist. 🔎 Justin E. Bird, MD, Associate Professor at MD Anderson Cancer Center, will add a clinical perspective. Albert Huang, MD, Chief Medical Advisor at Northgate Technologies Inc. and MedTech Executive at Lifeblood Capital, will share insights on the Houston MedTech sector. 📈 Bob Shaw, Board Member and Chair of the Life Sciences Committee at the Houston Angel Network, will provide a view on funding and ecosystem support. Meagan Pitcher, CEO & Co-Founder of Bairitone Health, and 🦸♀️ Swarna Balasubramaniam, MD, Founder & CEO of Noleus Technologies, will round out the session with their experiences in Houston’s MedTech environment. 🤝 Interested in being part of #MedTechMalta2024 from Nov 6-8 in #Valletta, Malta? Apply today to speak! https://lnkd.in/dBaxK53d ✨ Supported by: Lifeblood, Malta Enterprise, VisitMalta Incentives & Meetings, Malta Digital Innovation Authority, Ministry for Health and Active Ageing, Government of Malta.